Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombocytopenic Purpura”

529 trials

Showing 20 of 529 results

Early research (Phase 1)Looking for participantsNCT07083960
What this trial is testing

OM336 in Autoimmune Cytopenias

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic AnemiaITP - Immune Thrombocytopenia
Ouro Medicines 32
Very early researchStudy completedNCT00486421
What this trial is testing

Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura

Who this might be right for
Nonneoplastic Condition
Mayo Clinic 22
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24
Large-scale testing (Phase 3)Study completedNCT00909077
What this trial is testing

The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Copenhagen University Hospital at Herlev 155
Testing effectiveness (Phase 2)UnknownNCT06176911
What this trial is testing

The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 124
Testing effectiveness (Phase 2)Ended earlyNCT01054443
What this trial is testing

Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Shionogi 20
Not applicableStudy completedNCT01416311
What this trial is testing

Drug Use Investigation for REVOLADE (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
Novartis Pharmaceuticals 5,797
Large-scale testing (Phase 3)Study completedNCT00511147
What this trial is testing

IGIV Study for Chronic ITP Patients Ages 3-70

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Grifols Biologicals, LLC 64
Large-scale testing (Phase 3)Study completedNCT00102336
What this trial is testing

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 62
Testing effectiveness (Phase 2)Looking for participantsNCT06658834
What this trial is testing

Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 129
Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Large-scale testing (Phase 3)WithdrawnNCT01734057
What this trial is testing

Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University
Testing effectiveness (Phase 2)Study completedNCT05694767
What this trial is testing

A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 22
Not applicableStudy completedNCT01672151
What this trial is testing

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Post-approval studies (Phase 4)Study completedNCT02760251
What this trial is testing

Immunomodulation With Romiplostim in Young Adults With ITP

Who this might be right for
Immune Thrombocytopenia
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Study completedNCT00128882
What this trial is testing

Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

Who this might be right for
Idiopathic Thrombocytopenic Purpura
University of Aarhus 45
Not applicableLooking for participantsNCT06919341
What this trial is testing

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

Who this might be right for
ITP - Immune ThrombocytopeniaPrimary Immune Thrombocytopenia (ITP)
Fundación Española de Hematología y Hemoterapía 1,000
Large-scale testing (Phase 3)Study completedNCT05220878
What this trial is testing

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Large-scale testing (Phase 3)Study completedNCT00102323
What this trial is testing

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 63
Large-scale testing (Phase 3)Study completedNCT00749112
What this trial is testing

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Who this might be right for
Idiopathic Thrombocytopenic PurpuraAnemia, Hemolytic, Autoimmune
Hospital Universitario Dr. Jose E. Gonzalez 19
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation